European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
Extracapsular dissection versus partial superficial parotidectomy: a systematic review and meta-analysis.
СтатьяСистематический обзорМетаанализСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lee Yi-Chan, Lin Wan-Ni, Tsai Yao-Te, Tsai Tsung-You, Fang Tuan-Jen, Su Shih-Chi, Luo Cheng-Ming, Hsieh Rodney Cheng-En, Hsin Li-Jen
Аннотация
PURPOSE: To compare perioperative outcomes and surgical safety between extracapsular dissection (ECD) and partial superficial parotidectomy (PSP) for benign parotid tumors through a systematic review and meta-analysis.
METHODS: PubMed, Embase, and the Cochrane Library were searched for studies published up to March 2025. English-language studies that directly compared ECD and PSP in patients with benign parotid tumors were included. Data were extracted independently by two authors, and meta-analyses were conducted using a random-effects model. Outcomes included operative duration, drainage volume, hospital stay, tumor size, incidences of Frey syndrome, facial nerve (FN) injury (temporary and permanent), recurrence, as well as the rate of complete tumor excision.
RESULTS: Fourteen studies met the inclusion criteria. Compared with PSP, ECD was associated with shorter operative duration (mean difference [MD], - 15.42 min; 95% confidence interval [CI], - 23.47 to - 7.37), lower drainage volume (MD, - 31.32 mL; 95% CI, - 32.88 to - 29.76), shorter hospital stay (MD, - 0.54 days; 95% CI, - 0.78 to - 0.29), and reduced rates of both Frey syndrome (risk difference [RD], - 0.03; 95% CI, - 0.05 to - 0.00) and temporary FN injury (RD, - 0.12; 95% CI, - 0.20 to - 0.05). No significant differences were found in tumor size, recurrence, permanent FN injury, complete excision rate, or other complications.
CONCLUSION: ECD and PSP demonstrate comparable surgical safety for benign parotid tumors. ECD offers certain perioperative advantages and may be a suitable option for appropriately selected patients. Further prospective studies are warranted to confirm these findings.
METHODS: PubMed, Embase, and the Cochrane Library were searched for studies published up to March 2025. English-language studies that directly compared ECD and PSP in patients with benign parotid tumors were included. Data were extracted independently by two authors, and meta-analyses were conducted using a random-effects model. Outcomes included operative duration, drainage volume, hospital stay, tumor size, incidences of Frey syndrome, facial nerve (FN) injury (temporary and permanent), recurrence, as well as the rate of complete tumor excision.
RESULTS: Fourteen studies met the inclusion criteria. Compared with PSP, ECD was associated with shorter operative duration (mean difference [MD], - 15.42 min; 95% confidence interval [CI], - 23.47 to - 7.37), lower drainage volume (MD, - 31.32 mL; 95% CI, - 32.88 to - 29.76), shorter hospital stay (MD, - 0.54 days; 95% CI, - 0.78 to - 0.29), and reduced rates of both Frey syndrome (risk difference [RD], - 0.03; 95% CI, - 0.05 to - 0.00) and temporary FN injury (RD, - 0.12; 95% CI, - 0.20 to - 0.05). No significant differences were found in tumor size, recurrence, permanent FN injury, complete excision rate, or other complications.
CONCLUSION: ECD and PSP demonstrate comparable surgical safety for benign parotid tumors. ECD offers certain perioperative advantages and may be a suitable option for appropriately selected patients. Further prospective studies are warranted to confirm these findings.